Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NICE guidance on cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen.

× No keyword cloud information.

3 in total

1. New immunotherapeutic paradigms for castration-resistant prostate cancer.

Authors: Lorenzo Galluzzi
Journal: Oncoimmunology Date: 2013-08-07 Impact factor: 8.110

2. Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis.

Authors: Lixian Zhong; Vickie Pon; Sandy Srinivas; Nicole Nguyen; Meghan Frear; Sherry Kwon; Cynthia Gong; Robert Malmstrom; Leslie Wilson
Journal: PLoS One Date: 2013-05-22 Impact factor: 3.240

3. Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).

Authors: Joanna C Thorn; Emma L Turner; Luke Hounsome; Eleanor Walsh; Liz Down; Julia Verne; Jenny L Donovan; David E Neal; Freddie C Hamdy; Richard M Martin; Sian M Noble
Journal: BMJ Open Date: 2016-04-29 Impact factor: 2.692

3 in total